Krystal Biotech
KRYS
KRYS
272 hedge funds and large institutions have $3.8B invested in Krystal Biotech in 2025 Q2 according to their latest regulatory filings, with 41 funds opening new positions, 100 increasing their positions, 97 reducing their positions, and 63 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
272
Holders Change
-26
Holders Change %
-8.72%
% of All Funds
3.65%
Holding in Top 10
7
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
41
Increased
100
Reduced
97
Closed
63
Calls
$60.6M
Puts
$68M
Net Calls
-$7.49M
Net Calls Change
-$44M
Top Buyers
| 1 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$66.1M |
| 2 |
B
Braidwell
Stamford,
Connecticut
|
+$45M |
| 3 |
Goldman Sachs
New York
|
+$40.8M |
| 4 |
First Trust Advisors
Wheaton,
Illinois
|
+$26M |
| 5 |
RAM
Readystate Asset Management
Chicago,
Illinois
|
+$20.3M |
Top Sellers
| 1 |
UBS AM
Chicago,
Illinois
|
-$46.9M |
| 2 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$33.5M |
| 3 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$27.3M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$25.2M |
| 5 |
1832 Asset Management
Toronto,
Ontario, Canada
|
-$24.5M |
